Psilocybin is a rather poorly studied component of the so-called "magic mushrooms" – despite the fact that humanity has encountered it for a long time and knows exactly its properties and effects, from a scientific point of view, psilocybin continues to be a rather intriguing compound. That is why many teams of researchers in the field of neurobiology and neurophysiology seek to uncover certain features and hidden benefits of this psychoactive component, which could be useful and even determinative in the treatment of a wide range of mental illnesses such as depression, anxiety and post-traumatic disorder.
Today, a team of specialists from several US universities in the new issue of the scientific journal The Journal of Psychedelic Studies talked about how psilocybin, extracted and appropriately modified for medical purposes, can serve as more than a promising tool for fighting not only depression, but also obsessive – compulsive disorder, which is a rather serious disorder of the psyche and brain function. The research team came to such conclusions after relatively short, but backed by a fairly broad research base of early studies, experiments in which patients with varying degrees of obsessive-compulsive disorder took part.
A growing body of research suggests psychedelic mushrooms may have therapeutic benefits for certain conditions. Now a movement seeks to decriminalize them.
It is important to note that in the study of specialists, it was about the use of microdoses, which are several tens, or even hundreds of times less than those used outside the medical field of research.
It is worth noting that microdoses of psilocybin have previously shown very promising results in minimizing the effects of protracted depression and associated cognitive impairment – although until now, the true nature and hidden properties of psilocybin may still emerge under certain conditions. That is why scientists intend to continue their series of experiments on it.